Blog
Pediatric News
Vicks VapoRub Poses Risk to Children Under Two
Posted by: William Cirignani
January 16, 2009
A recent study in Chest, the medical journal of the American College of Chest Physicians, cautions that the popular cold remedy VapoRub can stimulate mucus production causing airway inflammation when used on infants and toddlers. This reaction can severely affect young children’s breathing. Once again, caution is the word with cold medications in children under two, even over-the-counter meds.
News
Personal Injury
[02/07] Oregon copter pilot has knack for finding the lost
[02/07] A push for family input to detect dementia earlier
[02/07] Judge allocates time for start of oil spill trial
[02/07] Blood clot guidelines challenge economy class risk
[02/06] Ga. court to hear case of possible gator attack
[02/06] Police: Man accidentally shoots self at gun show
[02/06] Mushroom pickers lost hope, considered eating dog
[02/06] 3rd US cruise ship sails after virus outbreak
[02/03] 35 cases of illness tied to Pa. farm's raw milk
[02/03] Maine girl bouncing back after 6-organ transplant
Read More
Topics
Animal Health
Birth News (Obstetrics)
Breast Cancer News
Consumer Rights And Medical Malpractice Reform
Hospital News
Medical Devices
Medical Error: Medications and Overdose
Medical Error: Misdiagnosis
Medical Research
Nursing Home Care
Pediatric News
Recent Updates
December 15, 2009
Radiation Overexposure from CT Scans More Widespread
January 16, 2009
Tobacco Settlements?Ten Years Later
January 16, 2009
Deceased woman?s family awarded $16.6 million for pain patch lawsuit
January 16, 2009
Antibiotic Overdose
January 16, 2009
Vicks VapoRub Poses Risk to Children Under Two
March 27, 2008
Narcotic Overdose and Other Problems
March 27, 2008
Accessing Medical Records
October 25, 2007
Drug Manufacturers Wake-Up And Pull OTC Cold Medications
October 25, 2007
Doctor Discipline
August 21, 2007
How Doctors Think
